Abstract Background Interstitial lung diseases (ILDs) can be induced and even exacerbated
by radiotherapy in thoracic cancer patients. The roles of immune responses underlying the …

Objective Accurate imaging biomarkers that indicate disease progression at an early stage
are highly important to enable timely mitigation of symptoms in progressive lung disease. In …

Molecular targeted therapy significantly improved the therapeutic efficacy in non-small cell
lung cancer (NSCLC) patients with driver gene mutations but also with new toxicity profiles …

Invariably fatal and with a particularly fast progression, pulmonary fibrosis (PF) is currently
devoid of curative treatment options. Routine clinical diagnosis relies on breathing tests and …

Computed Tomography (CT) is a standard clinical tool utilized to diagnose known lung
pathologies based on established grading methods. However, for preclinical trials and …

Purpose The association between the process of postoperative pneumonia and lung cancer
recurrence remains elusive in lung cancer surgery. Herein, the association between …

Drug-induced interstitial lung disease (DIILD) is a clinical entity bearing significant morbidity
and mortality that presents with non-specific symptoms, more frequently cough, dyspnea …